| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Mineralys Therapeutics, Inc. (MLYS) has 8 insiders with recent SEC Form 4 filings, including 4 buys and 0 sells. MLYS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 7.90M | $212.46M | - | |
| Dir | 5.46M | $146.67M | - | |
| CEO | 689.3K | $18.53M | - | |
| Dir | 588.2K | $15.81M | - | |
| Other | 57.1K | $1.53M | -14,474 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 14, 2023 | Hbm Healthcare Investments (cayman) Ltd. | 10% Owner | Buy | 312,500 | $16.00 | $5,000,000.00 | +10.8% | -10.1% | -19.3% | |
| Feb 14, 2023 | Slingsby Brian Taylor48 | Director, 10% Owner | Buy | 250,000 | $16.00 | $4,000,000.00 | +2.8% | -10.1% | -19.3% | |
| Feb 14, 2023 | Ra Capital Management, L.P.53 | Director | Buy | 1,250,000 | $16.00 | $20,000,000.00 | +64.8% | -10.1% | -19.3% |